Doubling calcium and phosphate concentrations in neonatal parenteral nutrition solutions using monobasic potassium phosphate

被引:19
作者
Wong, JC
McDougal, AR
Tofan, M
Aulakh, J
Pineault, M
Chessex, P
机构
[1] Childrens & Womens Hlth Ctr BC, Div Neonatol, Vancouver, BC V6H 3V4, Canada
[2] Childrens & Womens Hlth Ctr BC, Dept Pharm, Vancouver, BC V6H 3V4, Canada
[3] Hop St Justine, Dept Pharm, Montreal, PQ H3T 1C5, Canada
关键词
total parenteral nutrition; mineral content; solubility; phosphate; calcium; neonatal;
D O I
10.1080/07315724.2006.10719517
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Premature infants require high intakes of Ca and P to mimic fetal accretion rates. With the current phosphate salt used, adequate amounts cannot be provided due to the precipitation of Ca and P in TPN solutions. Objective: To compare monobasic potassium phosphate (monobasic regimen) and monobasic plus dibasic potassium phosphate (dibasic regimen) on calcium phosphate solubility in 5 amino acid products, and to determine whether solubility differences observed in these products can be explained by buffering capacity. Methods: TPN solutions were prepared according to standard clinical practice. The following amino acid products were used at 3% concentrations: Primene, Vamin N, TrophAmine, Aminosyn-PF, and Travasol. Dextrose 10%, standard electrolytes, heparin, vitamins and trace elements were added. Calcium (as gluconate) and phosphate (as monobasic or dibasic regimen) were added in one-to-one molar ratios from 0-45 mmol/L. Solutions were inspected macroscopically and microscopically for precipitation under three conditions: immediately, 24 hafter preparation at room temperature, and 3 hlater in a 37 degrees C water bath. Buffering capacity was determined for each amino acid product by titrating with standardized 0.1 M NaOH. Results: Variations in Ca:P solubility and buffer capacity exist between amino acid solutions. With Primene and Vamin no macroscopic or microscopic precipitation was detected up to 45 mmol/L using monobasic regimen, compared to 25 mmol/L using dibasic regimen with Trophamine. Buffer capacity did not account for the solubility differences observed between the five amino acid products, which were related to the pH of the final solution. Conclusions: These data will allow clinicians to double the current concentrations of calcium and phosphate in neonatal TPN solutions using monobasic regimen. Although this is particularly relevant to situations when fluid intake is restricted, the effect of the acid load needs to be investigated in extremely low birth weight infants.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 52 条
[1]  
*ABB LAB, 1997, PROD MON ABB LAB
[2]   NEPHROCALCINOSIS [J].
ADAMS, ND ;
ROWE, JC .
CLINICS IN PERINATOLOGY, 1992, 19 (01) :179-195
[3]   Compatibility and stability of additives in parenteral nutrition admixtures [J].
Allwood, MC ;
Kearney, MCJ .
NUTRITION, 1998, 14 (09) :697-706
[4]  
ATKINSON SA, 1983, NUTR REV, V41, P69, DOI 10.1111/j.1753-4887.1983.tb07705.x
[5]  
*B BRAUN MED INC, 1999, TROPH AM AC INJ PROD
[6]  
BOULET M, 1980, ARCH BIOCHEM BIOPHYS, V96, P629
[7]   CALCIUM-PHOSPHATE CRYSTAL OCCLUSION OF CENTRAL VENOUS CATHETERS USED FOR TOTAL PARENTERAL-NUTRITION IN INFANTS AND CHILDREN - PREVENTION AND TREATMENT [J].
BREAUX, CW ;
DUKE, D ;
GEORGESON, KE ;
MESTRE, JR .
JOURNAL OF PEDIATRIC SURGERY, 1987, 22 (09) :829-832
[8]   METABOLIC BONE-DISEASE IN PRETERM INFANTS [J].
BROOKE, OG ;
LUCAS, A .
ARCHIVES OF DISEASE IN CHILDHOOD, 1985, 60 (07) :682-685
[9]   HOME PARENTERAL-NUTRITION IN INFANTS [J].
CANNON, RA ;
BYRNE, WJ ;
AMENT, ME ;
GATES, B ;
OCONNOR, M ;
FONKALSRUD, EW .
JOURNAL OF PEDIATRICS, 1980, 96 (06) :1098-1104
[10]  
CHAN JCM, 1972, J AMER MED ASSOC, V220, P1119